HealthMore in Health→
New multiple myeloma study argues high-risk definition should shift to a three-year window
Key Takeaways
- Researchers propose redefining functional high-risk multiple myeloma around progression within 36 months, not 18 months.
- The study analyzed 310 newly diagnosed patients treated with quadruplet therapy and autologous stem cell transplantation.
- The identified FHR36 group made up 16.4% of treated patients and may merit earlier access to T-cell redirecting therapy and novel-drug trials.
DE
DT Editorial Team··via medicalxpress.com